Nahdi Medical Company (4164.SR) SAU
106.50
-0.5(-0.47%)
Currency In SAR
- General
- Statistics
- Historical Data
- Profile
- Financials
106.50
-0.5(-0.47%)
Currency In SAR
| Market Cap | 15.29B |
| Enterprise Value | 15.86B |
| P/E Ratio | 17.04 |
| PEG Ratio | -6.81 |
| Price/Sales Ratio | 1.39 |
| Price/Book Ratio | 5.5 |
| Enterprise/Revenue | 1.5 |
| Enterprise/EBITDA | 8.77 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.08 |
| Operating Margin | 0.09 |
| Return On Assets | 0.12 |
| Return On Equity | 0.32 |
| Revenue | 9.45B |
| Revenue/Share | 76.82 |
| Gross Profit | 3.53B |
| EBITDA | 1.61B |
| Net Income | 820.72M |
| Diluted EPS | 6.31 |
| Total Cash | 638.16M |
| Total Cash/Share | 4.91 |
| Total Debt | 1.8B |
| Total Debt/Equity | 0.71 |
| Current Ratio | 1.4 |
| Book Value Per Share | 19.35 |
| 52-Week Change | -9.28 |
| 52-Week High | 132.1 |
| 52-Week Low | 91 |
| Moving Average 50 Days | 97.22 |
| Moving Average 200 Days | 111.07 |
| Average Volume | 220,297 |
| Shares Outstanding | 130M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 5.6 |
| Trailing Annual Dividend Yield | 5.26 |
| Payout Ratio | 0.9 |
| Last Split Factor | N/A |
| Last Split Date | N/A |